Navigation Links
FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
Date:5/4/2010

eling is based on a 14-hour modified analog classroom study of Vyvanse to simulate a workplace environment in 142 adults who met DSM-IV-TR criteria for ADHD.  The data support the results of a previous Phase 3 clinical study of adults with ADHD in which Vyvanse significantly improved the ADHD symptoms of inattention (for example, lack of focus), as well as of hyperactivity and impulsivity, as measured by the ADHD Rating Scale (ADHD-RS-IV) with adult prompts, a standard validated tool.  The most common treatment-emergent adverse events in patients taking Vyvanse in this previous study were decreased appetite, trouble sleeping, dry mouth, nausea, diarrhea, anxiety and loss of appetite.

As with other stimulant medications, Vyvanse is classified as a controlled substance (CII) because of its potential for abuse.

About the Study

The data that led to this approval of revised labeling for Vyvanse was from a multi-center, randomized, double-blind, placebo-controlled, crossover study in 142 adults who met DSM-IV-TR criteria for ADHD.  Following a 4-week, open-label, dose-optimization phase with Vyvanse (30, 50, or 70 mg/day in the morning), subjects were randomized to one of two treatment sequences:  Vyvanse (optimized dose) followed by placebo, each for one week, or placebo followed by Vyvanse, each for one week.  Efficacy assessments occurred at the end of each week, using the PERMP.  The PERMP is a skill-adjusted math test that measures attention in ADHD.  Vyvanse treatment, compared to placebo, resulted in a statistically significant improvement in attention across all postdose time poin
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
2. FDA Approves New Device for Adults with Severe and Persistent Asthma
3. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
4. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
5. FDA Approves First Totally Implanted Hearing System
6. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
7. FDA Approves Name Change for Heartburn Drug Kapidex
8. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
9. FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade
10. FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinsons Disease
11. FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Die Apex Medical Corporation (Apex, ... Atemtherapie- und Druckzonenprodukte, gibt bekannt, dass sie ... anfechten werden. Dieses hat entschieden, dass die ... ResMed verletze. Apex weist darauf hin, dass ... Patente von ResMed Anfechtungen wegen Nichtigkeit eingeleitet ...
(Date:7/29/2014)... 2014 /PRNewswire-iReach/ -- The global microbial identification market ... applications, end users, and geographies. Genotypic technology is ... identification market. This favorable growth is attributed to ... the time required for microbial identification along with ... genotypic methods have high applications in clinical diagnostics ...
(Date:7/29/2014)... 2014  Express Scripts Holding Company (Nasdaq: ... to Express Scripts stockholders of $515.2 million, or $0.67 ... detailed in Table 4, was $1.23 for the second ... to serve our clients with scale, alignment and innovative solutions ... health outcomes of our members," stated George Paz, chairman and ...
Breaking Medicine Technology:Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 2Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 3Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 4Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 5Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 8Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 9Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 10Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 11Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 12Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 13Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 14Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 15Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 16Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 17Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 18Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 19Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 20Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 21Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 22Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 23Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 24Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 26Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 27Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 28Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 29
... YORK, Sept. 15, 2011 Close to 100 openly HIV-positive ... around the world have signed a new letter ( http://tinyurl.com/pozPrEPletter ... than on fear or misinformation," of the challenges and opportunities ... and bisexual men and transgender women. The new open letter ...
... Qualitest Pharmaceuticals today issued a voluntary, nationwide, retail-level ... is being implemented because of a packaging error, where ... reversing the weekly tablet orientation and making the lot ... error and the potential for this error to have ...
Cached Medicine Technology:Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP) 2Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP) 3Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives 2
(Date:7/30/2014)... accurate tests could be created to diagnose diseases such ... leading to earlier intervention, according to new findings from ... investigating the components of memory using a combination of ... used to create a diagnostic tool for distinguishing between ... forms of amnesia caused by head trauma. , ...
(Date:7/30/2014)... Victory Medical Center Craig Ranch ... the launch of a pediatric unit focused on: orthopedics, ... doctors working in the pediatrics departments are all specially ... adolescents. Dr. Timothy Cole, Dr. Dale Ehmer, Dr. Barry ... Mehendale, and Dr. Nicholas Peiffer lead the pediatrics team. ...
(Date:7/30/2014)... July 30, 2014 Los Angeles ... cosmetic dental treatments that can help patients create their ... Healthy teeth and gums form the foundation of smile ... While minor chips, misshapen teeth or stains may not ... a smile’s appearance. The right cosmetic treatments can eliminate ...
(Date:7/30/2014)... July 30, 2014 Dialogic ... today announced that DollarPhone, the largest privately owned ... the Dialogic® ControlSwitch™ softswitch to offer ... number portability (LNP) to both its wholesale and ... ControlSwitch is able to power DollarPhone’s network infrastructure, ...
(Date:7/30/2014)... 30, 2014 According to the American Cancer ... diagnosed in the United States in 2014. (1) ... for the mortgage and financial industry, has long been a ... cure, and the company has further demonstrated its commitment by ... Harbor & Tarpon Springs event to increase awareness and fundraising ...
Breaking Medicine News(10 mins):Health News:Hope for more accurate diagnosis of memory problems 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 3Health News:DollarPhone Expands Prepaid and Wholesale Offerings With Enhanced Dialogic ControlSwitch 2Health News:DollarPhone Expands Prepaid and Wholesale Offerings With Enhanced Dialogic ControlSwitch 3Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 2Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 3Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 4
... offers hope for babies born with craniosynostosis, a condition that ... Implants replacing some of the infant,s bone with the biodegradable ... treat the condition. "The remarkable thing about this is ... the cells around it do. Cells begin producing natural drugs ...
... ... memory as well as prevent and even reverse mental atrophy, has lead to a surge ... website, has seen a 40% growth in traffic alone in the last 6 months. ... (PRWEB) November 19, 2009 -- ...
... 19 As negotiators on Capitol Hill try to find ways ... surgery has been introduced on Nov. 18 as part of the ... (D-NV). The American Academy of Cosmetic Surgery strongly opposes such ... A tax on elective cosmetic procedures is an unreliable, risky revenue ...
... General President Jim Hoffa , WASHINGTON, Nov. 19 ... today about the Senate plan to impose an excise tax ... huge middle-class tax hike to workers: , "The Senate plan ... insurers for higher-cost health plans that is simply a huge ...
... of The Lancet Infectious Diseases brings to light ... pathogen the influenza virus and its impact on ... diseases specialist Leonard Mermel, DO, medical director of infection control ... light of the H1N1 pandemic, what past research tells us ...
... , Individualized Decision Between Woman and Her Provider is ... 19 "The controversy around mammography emphasizes that the best ... health care provider. Balancing a woman,s individual medical history, risks, ... the individual level using guidelines as a guide and not ...
Cached Medicine News:Health News:Bone implant offers hope for skull deformities 2Health News:Feed the Mind: Brain Metrix Experiences Tremendous Growth with Popularity of Brain Fitness Games 2Health News:Feed the Mind: Brain Metrix Experiences Tremendous Growth with Popularity of Brain Fitness Games 3Health News:American Academy of Cosmetic Surgery Opposes Cosmetic Surgery Tax 2Health News:Preventing H1N1 spread to health care workers: Dilemma, debate and confusion 2Health News:Breaking Through the Mammography Controversy 2
... BVM 6500 enables physicians ... determine UEBW (ultrasound estimated ... volume using 3-dimensional V-mode ... was designed to assist ...
... The MIS is designed to facilitate ... the area of the mid-urethra. Either ... minutes, and can be performed under ... which allows the patient to return ...
... 650™ and 600M™ malleable penile prostheses offer ... with limited dexterity. These implants are always ... to position them in an erect or ... rigid enough for sexual intercourse and to ...
... The AMS 650™ and 600M™ malleable penile ... patientsespecially those with limited dexterity. These implants ... the patient to position them in an ... the penis rigid enough for sexual intercourse ...
Medicine Products: